Mustang Bio Inc. (MBIO)
NASDAQ · Healthcare
Mustang Bio Inc. EBITDA 2020–2025
Mustang Bio Inc. annual/quarterly ebitda history and growth rate from 2020 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Mustang Bio Inc. ebitda for the quarter ending March 31, 2026 was -1.1 M, a 399.06% increase year-over-year.
- Mustang Bio Inc. ebitda for the twelve months ending March 31, 2026 was -3.2 M.
- Mustang Bio Inc. annual ebitda for 2025 was -2.4 M, a 78.71% decrease from 2024.
- Mustang Bio Inc. annual ebitda for 2024 was -11.2 M, a 75.97% decrease from 2023.
- Mustang Bio Inc. annual ebitda for 2023 was -46.7 M, a 34.30% decrease from 2022.
- Mustang Bio Inc. annual ebitda for 2022 was -71.1 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Mustang Bio Inc. EBITDA — FAQ
Mustang Bio Inc. (MBIO) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see MBIO's ebitda history?
The chart and table above show Mustang Bio Inc.'s ebitda by year and by quarter, including the growth rate.